Viby Sachet

Introduction

Viby Sachet is a prescription medication that contains the active ingredient Vigabatrin. Vigabatrin is an antiepileptic drug that is used to treat certain types of seizures in patients with epilepsy. It is available under the brand name Viby Sachet.

Uses

Viby Sachet is primarily prescribed for the treatment of infantile spasms, a type of seizure disorder that typically occurs in infants. It may also be used as an adjunctive therapy for the treatment of refractory complex partial seizures in adults and adolescents aged 16 years and older.

Dosage and Administration

The dosage of Viby Sachet will depend on various factors, such as the patient’s age, weight, and the specific condition being treated. Follow the instructions provided by your healthcare professional. Viby Sachet is usually taken orally, and the sachet should be dissolved in a small amount of water or other liquid before administration. The medication can be taken with or without food, as directed by your doctor.

Mechanism of Action

Vigabatrin, the active ingredient in Viby Sachet, works by increasing the levels of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain. GABA helps to reduce the excessive electrical activity that can lead to seizures. By increasing GABA levels, Vigabatrin helps to control seizures and prevent their occurrence.

Side Effects

Common side effects may include drowsiness, dizziness, fatigue, headache, and nausea. These side effects are generally mild and temporary. However, if you experience any severe or persistent side effects, such as vision changes, mood changes, or signs of an allergic reaction (e.g., rash, itching, swelling), seek medical attention immediately.

Drug Interactions

Viby Sachet may interact with other medications, including certain antidepressants, anticonvulsants, and sedatives. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. They can determine if any interactions may occur and adjust your treatment plan accordingly.

Precautions

Before starting treatment with Viby Sachet, inform your healthcare professional about any medical conditions you have, especially if you have a history of depression, suicidal thoughts, or vision problems. This medication may not be suitable for everyone, and your doctor will consider your individual circumstances before prescribing it. Viby Sachet should not be abruptly discontinued, as this may increase the risk of seizures.

Storage

Viby Sachet should be stored at room temperature, away from moisture and direct sunlight. Keep the medication out of the reach of children and pets. Do not use Viby Sachet if the sachet is damaged or if the expiration date has passed. If you have any unused medication, consult with your pharmacist or healthcare professional for proper disposal.

Patient Tips

• Take Viby Sachet exactly as prescribed by your healthcare professional.
• If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Avoid driving or operating machinery if you feel drowsy or dizzy after taking Viby Sachet.
• attend regular check-ups with your healthcare professional to monitor your response to the medication and adjust the dosage if necessary.
• If you have any questions or concerns about Viby Sachet, do not hesitate to speak with your doctor or pharmacist. They are there to provide guidance and support throughout your treatment journey.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Kigabeq (vigabatrin) 100mg (Health Professionals SmPC) Available at:
• Vigabatrin (Drugs.com) [Accessed 13 Jun. 2024] (online) Available at:
• vigabatrin 500 mg oral powder packet (RX) [Accessed 12 Jun. 2024] (online) Available at:
• Vigabatrin (MedlinePlus) [Accessed 11 Jun. 2024] (online) Available at:
• Wheless JW, Ramsay RE, Collins SD. Vigabatrin. Neurotherapeutics. 2007 Jan;4(1):163-72. doi: 10.1016/j.nurt.2006.11.008. [Accessed 5 Jun. 2024] Available at: